What You Should Know: - J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. - The new team will focus on investing in both early and growth-stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity,
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Viome Raises $67M to Expand Microbiome & At-Home Test Kits
What You Should Know: - Viome Life Sciences, a mission-driven digital health company, announced additional $67M in funding toward its Series C round. - Led by Bold Capital Group, the $67M raise brings the company’s total funding to over $150M and will be used to support the development of its at-home tests that leverage precision nutrition to improve health and increase longevity by addressing the epidemic of chronic diseases, cancers, and aging. - Viome will expand its proprietary mRNA
Read More
Eyenuk Raises $26M for AI-Powered Eye Screening & Predictive Biomarkers
What You Should Know: - Eyenuk, Inc., a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, today announced it has secured $26 million in a Series A financing round, bringing the Company’s total funding to over $43 million. - The capital raise was led by AXA IM Alts and was joined by new and existing investors including T&W Medical A/S, A&C Foelsgaard Alternativer ApS, Kendall
Read More
Rockley Photonics Develops Smaller, Powerful Chip for Health Wearables
What You Should Know: - Rockley Photonics Holdings Limited, a global leader in photonics-based health monitoring and communications solutions, recently announced that it has developed what it believes to be the world’s first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications. - This groundbreaking achievement is expected to allow Rockley to further increase the density and reduce the size of its high-density spectrophotometer chips — which are already
Read More
Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
What You Should Know: - Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers. - The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
The Fast Pace of Cancer Research is Leaving Community Clinicians Behind
We are witnessing an accelerated pace of amazing breakthroughs and advancements in cancer care today, with new treatments emerging almost weekly and unprecedented opportunities to help improve patient outcomes every day. However, if a doctor is not working in an academic setting, reading every new paper, and recruiting patients for new studies, how can they be expected to keep up with the latest treatments and approaches to specific cancers? When
Read More
Withings Unveils New Body Comp Smart Scale & Health+ Service
What You Should Know: - Withings is reimagining the use of smart scales and home health optimization with the introduction of Body Comp, a complete body assessment scale measuring multiple biomarkers typically only assessed in a professional clinical setting, and Health+ an enhanced service providing detailed health analysis and tools to help people improve their health by building a health routine. - Bundled together, Body Comp and 12-month access to Health+ will be available from October
Read More
Syapse and Genesis Research Form RWE Partnership in Oncology
What You Should Know: - Today, Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases, announced that they have entered into a strategic partnership with Genesis Research. - This partnership will focus on conducting real-world evidence-based research that supports the development and launch of new and innovative treatments. - As part of the
Read More
Challenges and Opportunities for At-Home COPD Management
There are an estimated 16 million Americans who suffer from Chronic Obstructive Pulmonary Disease (COPD). Patients with COPD are frequently prescribed respiratory medication and given at-home treatment strategies designed to improve general wellness and improve airflow. These strategies may include smoking cessation, air quality control, exercise, and stress management. Unfortunately, despite the use of medication and widespread adoption of lifestyle strategies, COPD continues to represent a
Read More
Cedars-Sinai Accelerator Adds 10 New Digital Health Startups
What You Should Know: - Cedars-Sinai Accelerator, today announced its eighth accelerator class of ten new digital health startups. - From digital health mental health services to wearable devices to manage chronic asthma, these innovative healthcare-focused startups are working to transform health and healthcare delivery as part of the Los Angeles-based accelerator program. Cedars-Sinai Accelerator Overview During the three-month term, company representatives collaborate with
Read More
